94 related articles for article (PubMed ID: 2159304)
1. Enzymatic studies of the effect of Cu (II) on oxygen radical production stimulated by daunorubicin and ametantrone.
Tarasiuk J; Kolodziejczyk P; Borowski E
Biochem Pharmacol; 1990 May; 39(9):1405-10. PubMed ID: 2159304
[TBL] [Abstract][Full Text] [Related]
2. The essential role of anthraquinones as substrates for NADH dehydrogenase in their redox cycling activity.
Tarasiuk J; Garnier-Suillerot A; Stefańska B; Borowski E
Anticancer Drug Des; 1992 Aug; 7(4):329-40. PubMed ID: 1324690
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial NADH dehydrogenase-catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5-iminodaunorubicin.
Davies KJ; Doroshow JH; Hochstein P
FEBS Lett; 1983 Mar; 153(1):227-30. PubMed ID: 6298008
[No Abstract] [Full Text] [Related]
4. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase.
Davies KJ; Doroshow JH
J Biol Chem; 1986 Mar; 261(7):3060-7. PubMed ID: 3456345
[TBL] [Abstract][Full Text] [Related]
5. Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase.
Doroshow JH
Cancer Res; 1983 Oct; 43(10):4543-51. PubMed ID: 6309369
[TBL] [Abstract][Full Text] [Related]
6. Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines.
Kharasch ED; Novak RF
Arch Biochem Biophys; 1983 Jul; 224(2):682-94. PubMed ID: 6408991
[TBL] [Abstract][Full Text] [Related]
7. Anthracenedione activation by NADPH-cytochrome P-450 reductase; comparison with anthracyclines.
Kharasch ED; Novak RF
Biochem Pharmacol; 1981 Oct; 30(20):2881-4. PubMed ID: 6274352
[No Abstract] [Full Text] [Related]
8. NAD(P)H (quinone acceptor) oxidoreductase (DT-diaphorase)-mediated two-electron reduction of anthraquinone-based antitumour agents and generation of hydroxyl radicals.
Fisher GR; Gutierrez PL; Oldcorne MA; Patterson LH
Biochem Pharmacol; 1992 Feb; 43(3):575-85. PubMed ID: 1311584
[TBL] [Abstract][Full Text] [Related]
9. The ability of new sugar-modified derivatives of antitumor anthracycline, daunorubicin, to stimulate NAD(P)H oxidation in different cellular oxidoreductase systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase.
Pawłowska J; Priebe W; Paine MJ; Wolf CR; Borowski E; Tarasiuk J
Oncol Res; 2004; 14(10):469-74. PubMed ID: 15559760
[TBL] [Abstract][Full Text] [Related]
10. Reduction of oxygen by NADH/NADH dehydrogenase in the presence of adriamycin.
Thornalley PJ; Bannister WH; Bannister JV
Free Radic Res Commun; 1986; 2(3):163-71. PubMed ID: 2850270
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of the low activity of antitumor anthracenediones, mitoxantrone and ametantrone, in oxygen radical generation catalyzed by NADH dehydrogenase. Enzymatic and molecular modelling studies.
Tarasiuk J; Mazerski J; Tkaczyk-Gobis K; Borowski E
Eur J Med Chem; 2005 Apr; 40(4):321-8. PubMed ID: 15804531
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical studies of the iron(III)-carminomycin complex and evidence of the lack of stimulated superoxide production by NADH dehydrogenase.
Fiallo MM; Garnier-Suillerot A
Biochim Biophys Acta; 1985 May; 840(1):91-8. PubMed ID: 2986712
[TBL] [Abstract][Full Text] [Related]
13. Lack of competition between cytochrome c and anthraquinone type drugs for the reductive sites of NADH dehydrogenase.
Tarasiuk J; Garnier-Suillerot A; Borowski E
Biochem Pharmacol; 1989 Jul; 38(14):2285-9. PubMed ID: 2546562
[TBL] [Abstract][Full Text] [Related]
14. Low stimulation of NADH oxidation and oxygen consumption by 5-iminodaunorubicin and its derivatives.
Tarasiuk J; Stefańska B; Borowski E
Acta Biochim Pol; 1990; 37(2):251-9. PubMed ID: 2072983
[TBL] [Abstract][Full Text] [Related]
15. The ability of new formamidine sugar-modified derivatives of daunorubicin to stimulate free radical formation in three enzymatic systems: NADH dehydrogenase, NADPH cytochrome P450 reductase and xanthine oxidase.
Pawłowska J; Tarasiuk J; Borowski E; Wasowska M; Oszczapowicz I; Wolf CR
Acta Biochim Pol; 2000; 47(1):141-7. PubMed ID: 10961687
[TBL] [Abstract][Full Text] [Related]
16. Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins.
Kelner MJ; Bagnell R; Hale B; Alexander NM
Arch Biochem Biophys; 1988 May; 262(2):422-6. PubMed ID: 2835006
[TBL] [Abstract][Full Text] [Related]
17. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.
Turrens JF; Boveris A
Biochem J; 1980 Nov; 191(2):421-7. PubMed ID: 6263247
[TBL] [Abstract][Full Text] [Related]
18. Superoxide anion production by adriamycinol from cardiac sarcosomes and by mitochondrial NADH dehydrogenase.
Gervasi PG; Agrillo MR; Citti L; Danesi R; Del Tacca M
Anticancer Res; 1986; 6(5):1231-5. PubMed ID: 3026233
[TBL] [Abstract][Full Text] [Related]
19. DNA base modifications induced in isolated human chromatin by NADH dehydrogenase-catalyzed reduction of doxorubicin.
Akman SA; Doroshow JH; Burke TG; Dizdaroglu M
Biochemistry; 1992 Apr; 31(13):3500-6. PubMed ID: 1313297
[TBL] [Abstract][Full Text] [Related]
20. Nitroreductase activity of NADH dehydrogenase of the respiratory redox chain.
Smyth GE; Orsi BA
Biochem J; 1989 Feb; 257(3):859-63. PubMed ID: 2494990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
